Final NICE ME/CFS Guideline Published – Find Out The Big News!

The National Institute for Health and Care Excellence (NICE) has now published its ME/CFS guideline and we are delighted that they have finally listened to the ME community in several key areas. NICE delayed publication of this guideline in August after concerns were raised by a few Royal Colleges. Instead,…

Continue ReadingFinal NICE ME/CFS Guideline Published – Find Out The Big News!

NICE publishes ME/CFS guideline: evidence says GET & CBT cannot cure!

NICE ME/CFS guideline outlines steps for better diagnosis and management NICE has today published its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS). It is estimated that there are over 250,000 people in England and Wales with ME/CFS, with about 2.4 times as…

Continue ReadingNICE publishes ME/CFS guideline: evidence says GET & CBT cannot cure!

Solve ME’s Strategic Commitment, Critical Initiatives and Growing Team

Dear Solve community members, As summer evolves into autumn, I write to share news about our continuing evolution and growth. In the last several months, we deepened our strategic commitment to identifying diagnostics and treatments for people with ME/CFS and Long Covid, sharpened our focus on translational research, made significant…

Continue ReadingSolve ME’s Strategic Commitment, Critical Initiatives and Growing Team

Acte sobre COVID persistent i Síndromes de Sensibilització Central

El pròxim 4 de novembre podrem escoltar diverses ponències sobre les qüestions que sorgeixen al voltant dels efectes de les infeccions postvíriques. Creiem que pot ser d’interès escoltar el que els experts poden aportar. RESERVA’T LA DATA 4 de novembre de 2021 Punt de vista Familiars de persones afectades... Read…

Continue ReadingActe sobre COVID persistent i Síndromes de Sensibilització Central

The Clinical Treatment Act is Delivering Results

After three years of advocacy, Solve M.E. scored a concrete legislative victory with the passage of The Clinical Treatment Act. This covers clinical trial costs for qualifying 74.8M Medicaid participants — including ME/CFS patients — and provides resources for ME/CFS clinical trials. Lowering the costs and barriers for participation in clinical…

Continue ReadingThe Clinical Treatment Act is Delivering Results

Choose your top ten ME/CFS research priorities – UK survey launched

Take the survey The ME/CFS Priority Setting Partnership (PSP) is giving you the opportunity to define your top ten priorities for future ME/CFS research. In partnership with the James Lind Alliance, the ME/CFS Priority Setting Partnership is launching their second survey today. The research questions in this survey are based…

Continue ReadingChoose your top ten ME/CFS research priorities – UK survey launched